fda 505(b)(2) applications seminar part i: where does a 505(b)(2) fit?
Published 8 years ago • 2K plays • Length 8:00Download video MP4
Download video MP3
Similar videos
-
14:31
fda 505(b)(2) applications seminar part viii: q&a and discussion of 505(b)(2) applications
-
9:30
fda 505(b)(2) applications seminar part ii: the regulatory pathway
-
8:31
fda 505(b)(2) applications seminar part iv: the thin line between a 505(j) and 505(b)(2)
-
13:04
fda 505(b)(2) applications seminar part vii: case studies on 505(b)(2) applications
-
6:13
fda 505(b)(2) applications seminar part iii: developing a 505(b)(2) application
-
13:43
fda 505(b)(2) applications seminar part v: quiz time can you identify a (b)(2) application?
-
41:56
understanding data integrity (full seminar)
-
57:40
u.s. fda ectd requirements for drug master files (dmfs)
-
59:19
understanding us fda regulatory responsibilities for cell therapy companies
-
5:32
fda 505(b)(2) applications seminar part vi: recent statistics on 505(b)(2) ndas
-
19:33
us fda. 505(b)(2)
-
59:15
efficient use of 505 b2 pathway to enter us market
-
59:17
505 (b)(2) regulatory pathway: generic drug development strategies
-
1:09:54
webinar: overview of the 505(b)(2) regulatory pathway for nda
-
2:20:19
fda regulatory affairs webinar - asphalion
-
17:32
maintenance of your drug master file (dmf) (5 of 5)
-
1:01:39
success factors in your ind filing
-
17:30
the us drug master file process (2 of 5)
-
36:55
components of new drug application and biologics license application (5of15) redi– may 29-30, 2019
-
34:01
rdm workshop: regulatory guidance & evidentiary principles for dht development-bakul patel, fda/cdrh
-
1:48
medical devices fund – regulatory approval